Maryam Fouladi, MD, MSc, has been awarded the Marjory Johnson Chair in Translational Brain Tumor Research by Cincinnati Children’s Hospital Medical Center.

“This chair recognizes Dr. Fouladi’s achievements as an internationally respected leader in pediatric neuro-oncology, and her work to develop new approaches to treatment that transform care for children with brain tumors,” said John Perentesis, MD, FAAP, director of Oncology at Cincinnati Children’s.

Fouladi joined Cincinnati Children's in January of 2008 to serve as medical director of the Neuro-Oncology Center. She also directs the training of junior faculty and fellows in pediatric neuro-oncology.

Fouladi earned her undergraduate and medical degrees at the University of Toronto and completed her fellowship in hematology/oncology at the Hospital for Sick Children in Toronto.  She obtained specialized fellowship training in neuro-oncology and molecular pharmacology at St. Jude Children’s Research Hospital in Memphis, TN, and was appointed to the faculty there in 2000.

She was elected in 2012 as chair of the National Cancer Institute-funded Pediatric Brain Tumor Consortium. Fouladi also has led a number of important clinical trials, including some of the first clinical trials of everolimus, a drug that targets the mTOR molecular pathway in pediatric malignancies.

Fouladi has published more than 60 papers in journals including the Journal of Clinical Oncology, Cancer, Neuro-Oncology, The Lancet Oncology and Cancer Investigation. She also has received the Terry Fox Clinician Scientists Research Fellowship, John H. Crookston Travel Award, The American Society of Hematology Travel Award, Cooley’s Anemia Symposium Travel Award, Berlex Oncology Foundation Award, the Hospital for Sick Children Humanitarian Award and the Frederick F. Tisdale Award for Excellence in Research.